Suppr超能文献

多囊卵巢综合征患者的肠道微生物群:系统评价。

Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.

机构信息

School of Nursing, Lanzhou University, Lanzhou, China.

The Reproductive Medicine Special Hospital of the 1st Hospital of Lanzhou University, Key Laboratory for Reproductive Medicine and Embryo, Lanzhou, China.

出版信息

Reprod Sci. 2022 Jan;29(1):69-83. doi: 10.1007/s43032-020-00430-0. Epub 2021 Jan 6.

Abstract

Polycystic ovary Syndrome (PCOS) is one of the most popular diseases that cause menstrual dysfunction and infertility in women. Recently, the relationships between the gastrointestinal microbiome and metabolic disorders such as obesity, type 2 diabetes and PCOS have been discovered. However, the association between the gut microbiome and PCOS symptoms has not been well established. We systematically reviewed existing studies comparing gut microbial composition in PCOS and healthy volunteers to explore evidence for this association. A systematic search was carried out in PubMed, Embase, Cochrane Library, and Web of Science from inception to May 26, 2020, for all original cross-sectional, cohort, or case-control studies comparing the fecal microbiomes of patients with PCOS with microbiomes of healthy volunteers (controls). The primary outcomes were differences in specific gut microbes between patients with PCOS and controls. The search identified 256 citations; 10 studies were included. The total population study of these articles consists of 611 participants (including PCOS group and healthy controls group). Among the included 10 studies, nine studies compared α-diversity, and six studies demonstrated that α-diversity has a significant reduction in PCOS patients. Seven of them reported that there was a significant difference of β-diversity composition between healthy controls groups and PCOS patients. The most common bacterial alterations in PCOS patients included Bacteroidaceae, Coprococcus, Bacteroides, Prevotella, Lactobacillus, Parabacteroides, Escherichia/Shigella, and Faecalibacterium prausnitzii. No consensus has emerged from existing human studies of PCOS and gut microbiome concerning which bacterial taxa are most relevant to it. In this systematic review, we identified specific bacteria associated with microbiomes of patients with PCOS vs controls. Higher level of evidence is needed to determine whether these microbes are a product or cause of PCOS.

摘要

多囊卵巢综合征(PCOS)是引起女性月经功能障碍和不孕的最常见疾病之一。最近,人们发现胃肠道微生物组与肥胖、2 型糖尿病和 PCOS 等代谢紊乱之间存在关联。然而,肠道微生物组与 PCOS 症状之间的关联尚未得到很好的证实。我们系统地综述了现有的比较 PCOS 患者和健康志愿者肠道微生物组成的研究,以探讨这种关联的证据。我们在 PubMed、Embase、Cochrane 图书馆和 Web of Science 上进行了系统检索,检索时间从建库至 2020 年 5 月 26 日,检索了所有比较 PCOS 患者和健康志愿者粪便微生物组的横断面、队列或病例对照研究。主要结局是 PCOS 患者和对照组之间特定肠道微生物的差异。该检索共确定了 256 条引文,纳入了 10 项研究。这些文章的总人群研究包括 611 名参与者(包括 PCOS 组和健康对照组)。在纳入的 10 项研究中,有 9 项研究比较了 α-多样性,有 6 项研究表明 PCOS 患者的 α-多样性显著降低。其中 7 项研究报道健康对照组和 PCOS 患者之间β-多样性组成有显著差异。PCOS 患者中最常见的细菌变化包括拟杆菌科、粪球菌属、拟杆菌属、普雷沃氏菌属、乳杆菌属、副拟杆菌属、埃希氏菌/志贺氏菌属和普拉梭菌属。关于哪些细菌类群与 PCOS 最相关,现有的人类 PCOS 和肠道微生物组研究尚未达成共识。在本系统综述中,我们确定了与 PCOS 患者和对照组微生物组相关的特定细菌。需要更高水平的证据来确定这些微生物是 PCOS 的产物还是原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验